The GLP-1 revolution is reshaping obesity care, revealing how primary care economics and reimbursement gaps leave patients ...

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.

Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a ...

Nearly one in four U.S. households reports using a GLP-1 medication, and projections suggest that figure could rise to 35 ...

It’s estimated that about one in 10 Americans have taken a GLP‑1 weight‑loss drug, and demand is surging. Ads are everywhere, but so are concerns about safety, cost and ...

Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from Australia.

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked.

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...